Usio Inc. (USIO) stock soared 41.54% to $2.59 in the pre-market trading after declaring that it has entered into a non-binding Letter of Intent (LOI) to acquire the assets of Information Management Solutions, LLC (IMS). NeuroMetrix Inc. (NURO), a Medical Instruments & Supplies company, dropped about -8.03% at $2.75 in pre-market trading Wednesday. Cinedigm Corp. …
What changed for these 30 stocks in Pre Market Session Read More »
Talos Energy Inc. (NYSE: TALO) stock dropped -16.75% to $8.75 in the pre-market session after it recently confirmed that it has priced its subscribed public offering of the Company’s 8,250,000 common stock shares for anticipated net revenue of $73,425,000 before relevant fees and expenses. Also, the Company issued an option to the underwriter to buy …
That’s why Talos Energy Inc. (TALO) stock nose-dived in the Premarket trading session Read More »
On December 8, American stock exchanges closed at historic highs. The S&P 500 Index climbed 0.28% to 3702 points, the Dow Jones added 0.35%, the NASDAQ rose 0.5%. The purchases spurred hope for fiscal stimulus, as well as the start of the UK vaccine distribution. The health and energy sectors were the top gains, rising …
Early Morning Vibes: 3 Best Performing Stocks Under $3 Read More »
The estimates of Wall Street analysts for renewable energy firms are improving as policymakers announce massive electrification and carbon reduction programs. US President-elect Joe Biden’s administration is expected to be more involved in terms of transport electrification initiatives and environmental protection policies. In a recent survey, Goldman Sachs (GS), the largest investment bank, said that, …
Goldman Sachs Analysts Say Stocks Of EV Makers TSLA, Li Auto, NIO Could Rise Read More »
The trade dispute between the US and China may have an indirect and direct effect on the largest Chinese e-Commerce firms, Alibaba, Baidu, JD.com. The trade restrictions set by the U.S. for the world’s largest economy may have a significant effect on the production costs of American goods and components in that country, which are …
Rising U.S.-China Trade Tensions – How Alibaba, Baidu, JD.com Will Survive Read More »
Recon Technology, Ltd. (Nasdaq: RCON) stock was taking the aerial route in the after-market session as it surged 95.8% to $2.82, after a China-based independent solutions integrator in the oilfield service and environmental protection, electric power, and coal chemical industries, today announced its financial results for the fiscal year 2020. Compared to the fiscal year …
Atossa Therapeutics, Inc. (Nasdaq: ATOS) stock dropped down -38.46 to $0.88 in the Early hour’s session today after a clinical-stage biopharmaceutical corporation looking to find and grow novel drugs in areas of substantial unmet medical need with a current emphasis on breast cancer and COVID-19, revealed the offering of an underwritten public offering with estimated …
Why Atossa Therapeutics, Inc. (Nasdaq: ATOS) stock tumbled in the pre-market trading? Read More »
In the After-hours session last night, Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) surged 33.16% to $42.65 after a report of phase 1 clinical trial of RP-A501, the Company’s adeno-associated viral vector (AAV)-based gene therapy candidate expressing LAMP2B for the treatment of Danon Disease, today announces early results from its open-label, Phase 1 clinical trial of RP-A501. …
Pluristem Therapeutics Inc. (Nasdaq: PSTI) share nose-dived in the premarket session after the announcement by a leading regenerative medicine firm building a marketplace for new biotherapeutic drugs that the Independent Data Management Committee (DMC) of its global pivotal Phase III trial for the treatment of critical limb ischemia (CLI) released its recommendation letter after an …
Lipocine Inc. (NASDAQ: LPCN), shares jumped 22.62% in the after-hours after the announcement by the clinical-stage biotech firm focusing on metabolic and endocrine diseases, recently confirmed that the U.S. TLANDO, the oral testosterone medication for testosterone replacement therapy in adult males, has been tentatively approved by the Food and Drug Administration for disorders associated with …
Is this the news why Lipocine Inc. (NASDAQ: LPCN) shares took a hike in the After-hours? Read More »
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.